rss
Br J Ophthalmol doi:10.1136/bjo.2007.131706

Age-related macular degeneration and mortality from cardiovascular disease or stroke

  1. Jennifer S Tan (jennifer_tan{at}wmi.usyd.edu.au),
  2. Jie Jin Wang (jiejin_wang{at}wmi.usyd.edu.au),
  3. Gerald Liew (gerald_liew{at}wmi.usyd.edu.au),
  4. Elena Rochtchina (elena_rochtchina{at}wmi.usyd.edu.au),
  5. Paul Mitchell (paul_mitchell{at}wmi.usyd.edu.au)
  1. University of Sydney, Australia
  2. University of Sydney, Australia
  3. University of Sydney, Australia
  4. University of Sydney, Australia
  5. University of Sydney, Australia
    • Published Online First 29 February 2008

    Abstract

    Background/aims: Age-related macular degeneration (AMD) and vascular disease share similar risk factors. Recent data suggest AMD may independently predict stroke or coronary heart disease. We prospectively assessed the relationship between AMD and risk of stroke- or cardiovascular-related death in an Australian population.

    Methods: Of 3654 baseline participants (1992-4) aged 49+years, 2335 were re-examined after 5-years and 1952 after 10-years. Retinal photographs were graded using the Wisconsin System. History and physical examination provided data on possible risk factors. Deaths and cause of death were confirmed by data linkage with the Australian National Death Index. Risk ratios (RR) were estimated in Cox models.

    Results: Among persons aged <75 years at baseline, early AMD predicted a doubling of cardiovascular mortality (RR, 2.32; 95% confidence interval (CI), 1.03-5.19), over the next decade, after controlling for traditional cardiovascular risk factors. Late AMD predicted 5-fold higher cardiovascular mortality (RR, 5.57; CI, 1.35-22.99) and 10-fold higher stroke mortality (RR, 10.21; CI, 2.39-43.60) after adjusting for age and sex only. These associations were not present when persons older than 75 were included.

    Conclusion: AMD predicted stroke and cardiovascular events over the long-term in persons aged 49-75 years. This may have potential implications for new intravitreal anti-VEGF AMD therapies.

    Relevant Article

    • At a glance:At a glance
      • Harminder S Dua,
      • Arun D Singh
      Br J Ophthalmol 2008;92:443

    This Article

    1. Abstract
    2. PDF
    3. All versions of this article:
      1. bjo.2007.131706v1
      2. 92/4/509most recent

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.